Schering Merger Includes Legal Headaches For Merck

Law360, New York (March 9, 2009, 12:00 AM EDT) -- As Merck & Co. prepares to join forces with Schering-Plough Co. in a $41.1 billion deal, the drugmaker stands ready to inherit a host of legal problems — including antitrust, employment, intellectual property and product liability suits — right along with an expanded arsenal of drugs and medical technology.

On Monday, Merck and Schering revealed the proposed union, which, if approved by regulators, would be helmed by Merck Chairman and CEO Richard Clark and operate under the Merck name.

The news comes on the heels of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.